Scientists have developed a promising compound, CS2, that targets the core biological mechanisms of Parkinson's disease, potentially offering a new treatment avenue beyond symptom relief.
Sweden must increase strategic investments in European digital infrastructure and pharmaceutical innovation to safeguard its economic future and national security.
Johnson & Johnson's Nordic CEO warns Sweden must urgently increase investment and streamline efforts in pharmaceutical innovation to maintain competitiveness and improve patient access to new treatments.
The EU's new pharmaceutical legislation addresses innovation and access amid significant counterfeit medicine risks, emphasizing patient safety and drug authenticity.
Simon Olsson's AI-driven protein modeling research receives major ERC Consolidator Grant, advancing drug development innovation.
Investor Patrick Horber warns that EU pharmaceutical regulations could drive investment capital away from Sweden without stable, long-term regulatory clarity.
Nordic stock markets rose sharply on October 1, supported by the pharmaceutical sector's growth.
Fredrik Warg identifies the pharmaceutical sector as a top investment opportunity, citing its affordability and potential.
AstraZeneca's Baxdrostat significantly reduces blood pressure in resistant hypertension patients, marking a key trial success.